Retatrutide by Goldbond — 10mg per vial, 2 vials / box Research Peptide
The most potent metabolic research peptide available.
Trusted research-grade Retatrutide from Goldbond
Choose an option
Factory-sealed box containing 2 vials of 10mg each. Full combo pack with COA documentation, ready for immediate dispatch.
One 10mg vial from a sealed box.
🚚 Pan-India delivery · Cash on Delivery available
Triple Receptor Agonism
Simultaneously activates GLP-1, GIP, and glucagon receptors — the most complete metabolic signalling profile studied in any clinical-stage peptide.
Phase II Clinical Data
Jastreboff 2023 (NEJM) reported 24.2% bodyweight reduction at 48 weeks — the largest effect size published for any metabolic peptide in clinical trials.
Metabolic Flexibility
GIP and glucagon receptor activation complements GLP-1 appetite suppression with enhanced energy expenditure and improved lipid metabolism signalling.
Next-Generation Profile
Successor compound to semaglutide and tirzepatide in mechanism breadth — currently in Phase III trials globally as of 2024.
"Ordered Retatrutide from Peptigrid. The Goldbond COA was exactly what I needed for verification — clear batch documentation, properly sealed."
— Aditya S., Delhi · Verified Purchase"The sealed combo box arrived intact with all documentation. COA verified, purity confirmed. This is what research-grade sourcing should look like."
— Meera V., Bangalore · Verified PurchaseCommunity Insights
Self-reported by pep-pedia.org users. Not clinical evidence.
How Retatrutide Works
GLP-1 Activation
Suppresses appetite and slows gastric emptying via GLP-1R agonism — the same mechanism validated across semaglutide and liraglutide trials globally.
GIP + Glucagon
Simultaneously activates GIP receptors (enhancing insulin secretion and fat metabolism) and glucagon receptors (increasing energy expenditure and lipolysis).
Synergistic Effect
The triple agonism produces metabolic effects larger than any single pathway alone — documented in Jastreboff 2023 Phase II data with 24.2% weight reduction at 48 weeks.
Mechanism based on peer-reviewed research. For academic citations and documentation, contact our team via WhatsApp or Telegram.
Complementary Research Peptides
Full Specifications
Frequently Asked Questions
What makes Retatrutide different from semaglutide or tirzepatide?
Semaglutide is a GLP-1 mono-agonist. Tirzepatide (Mounjaro) is a dual GLP-1/GIP agonist. Retatrutide adds a third receptor — glucagon — making it the first triple agonist in clinical development. The glucagon receptor component adds energy expenditure and lipolysis effects not seen in dual agonists, which may explain the larger effect sizes in Phase II data.
What does the Phase II trial data show?
Jastreboff et al. (NEJM, 2023) reported that Retatrutide (8mg dose) produced 24.2% mean body weight reduction at 48 weeks in adults with obesity. This exceeded outcomes reported for semaglutide (~15%) and tirzepatide (~22%) in comparable timeframes, representing the largest effect size for any metabolic peptide in published Phase II data at that time.
Why is COA verification important for Retatrutide?
Retatrutide is a complex 39-amino-acid peptide with specific structural requirements for activity. A Certificate of Analysis (COA) confirms identity (typically via HPLC and mass spectrometry), purity, and batch consistency. Goldbond provides COA documentation with each sealed box — particularly important for research reproducibility with this compound.
Is this product available for research purchase in India?
Yes. This product is available as a research chemical for laboratory and in vitro research purposes in India. It is not approved for human consumption or therapeutic use. All purchases confirm research-only intent.
What is lyophilized powder and how is it used in research?
Lyophilization (freeze-drying) removes moisture while preserving peptide integrity — ensuring stability during shipping and long-term storage. In research settings, lyophilized peptides are reconstituted with bacteriostatic water before use.
Ready to order?
Triple agonist. COA verified. 10mg × 2 vials ready for dispatch.
COA verified · ≥99% HPLC purity · Pan-India delivery · Cash on Delivery available
Research Use Only
This product is intended solely for laboratory and research purposes. It is not intended for human consumption, therapeutic use, or as a food or drug product. By purchasing, you confirm that this product will be used exclusively for legitimate research applications.
